SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-133209
Filing Date
2024-05-07
Accepted
2024-05-07 16:39:08
Documents
19
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833388d8k.htm   iXBRL 8-K 25904
2 EX-99.1 d833388dex991.htm EX-99.1 105476
7 GRAPHIC g833388newsp6a.jpg GRAPHIC 10344
8 GRAPHIC g833388sp0005.jpg GRAPHIC 5928
9 GRAPHIC g833388sp005a.jpg GRAPHIC 2663
10 GRAPHIC g833388sp5.jpg GRAPHIC 10741
  Complete submission text file 0001193125-24-133209.txt   334392

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240507.xsd EX-101.SCH 3100
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240507_def.xml EX-101.DEF 13866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240507_lab.xml EX-101.LAB 22897
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240507_pre.xml EX-101.PRE 14704
22 EXTRACTED XBRL INSTANCE DOCUMENT d833388d8k_htm.xml XML 5893
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 24922673
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)